CNS Pharmaceuticals
CNSP • NASDAQ
CNS Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Rami Levin, with a market cap of $1.7M.
Market Cap$1.7M
Employees3.0
CEORami Levin
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 15, 2026 · in a monthQ4 2025
Financials
CNS Pharmaceuticals FAQ
Common questions about CNS Pharmaceuticals
CNS Pharmaceuticals is scheduled to report earnings for Q4 2025 on May 15, 2026.
CNS Pharmaceuticals has approximately 3 employees.